See also this year's filing and all EDGAR filings for this company.
PDF Report 0000827871_2018_Eagle_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000827871, Eagle Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 188,697,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 63,065,000 |
| 2 | PropertyPlantAndEquipmentNet | 6,820,000 |
| 3 | remainder_Assets | 11,478,000 |
| 4 | LiabilitiesCurrent | 47,302,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 71,416,000 |
| 9 | ResearchAndDevelopmentExpense | 32,607,000 |
| 10 | remainder_Expenses | 79,696,000 |
| 11 | remainder_Revenues | 236,707,000 |
| 12 | remainder_NetIncome | -1,045,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 270,060,000 |
| 1 | Liabilities | 47,302,000 |
| 2 | Expenses | 183,719,000 |
| 3 | Revenues | 236,707,000 |
| 4 | StockholdersEquity | 222,758,000 |
| 5 | NetIncome | 51,943,000 |
| 6 | ComprehensiveNetIncome | 51,943,000 |
| 7 | BaseVar | 369,416,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.39 |
| 9 | EconomicCapitalRatio | 3.95 |
Edgar->Model Mapping
Feature Distribution
Change over Time
